DILIN Overview | Retrospective | Prospective | Ancillary Studies | References | Links

Ancillary Studies

As a general policy, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites investigator-initiated research project applications for ancillary studies to ongoing, large-scale, clinical trials, epidemiological studies and disease databases supported by the Institute. These studies are focused on a wide range of diseases and conditions including diabetes, obesity, acute and chronic liver disease, chronic kidney disease, benign prostatic hyperplasia, among others. The NIDDK Program Announcement describes this policy in greater detail.

The DILIN studies are eligible for ancillary studies under this policy. The goal of any ancillary study must complement but not overlap or interfere with the primary and secondary objectives of DILIN. Moreover, each applicant must agree to abide by DILIN procedures for conducting these studies. Qualified and interested investigators are invited to consult:

• DILIN Ancillary Studies Policy

There can be long lead times, and it highly recommended that investigators contact the DILIN Study Chairman, Dr. Paul Watkins, at the University of North Carolina at Chapel Hill, 4-6 months before any grant application is due. His e-mail address is: pbwatkins@med.unc.edu

To Top